Steven M Stirdivant

This inventor holds 10 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Sirna Therapeutics, Inc., Merck Sharp + Dohme Corp.. Active years: 2013-2026.

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Cary, NC (US) (2013 - 2019)
Doylestown, PA (US) (2018 - 2024)

Company Filing History:

9 out of 140

Sirna Therapeutics, Inc.

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2013-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516321 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2026-01-06),

2. 11932854 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2024-03-19),

3. 11193126 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2021-12-07),

4. 10246714 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2019-04-02),

5. 9970005 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2018-05-15),

6. 9850491 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2017-12-26),

7. 9447420 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA) (2016-09-20),

8. 9260471 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2016-02-16),

9. 8835623 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2014-09-16),

10. 8518907 - RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) (2013-08-27),

Title: The Innovative Journey of Steven M Stirdivant

Introduction: Steven M Stirdivant, a talented inventor based in Cary, North Carolina, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Steven M Stirdivant holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Steven M Stirdivant has worked tirelessly to bring his ideas to life, revolutionizing industries such as telecommunications, robotics, and renewable energy along the way.

Collaborations: Throughout his career, Steven M Stirdivant has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, solidifying his reputation as a visionary inventor.

Conclusion: Steven M Stirdivant's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of technology, with a legacy that will continue to inspire future generations of inventors.